NasdaqCM - Delayed Quote USD
Fennec Pharmaceuticals Inc. (FENC)
8.25
-0.18
(-2.14%)
At close: June 9 at 4:00:01 PM EDT
8.38
+0.13
+(1.58%)
After hours: June 9 at 6:34:39 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| ANDRADE ROBERT C Chief Financial Officer | Stock Award(Grant) | May 30, 2025 | 160,951 |
| HACKMAN JEFFREY S Chief Executive Officer | Purchase | May 19, 2025 | 15,000 |
| HAIGH ADRIAN J Chief Operating Officer | Conversion of Exercise of derivative security | Apr 22, 2024 | 0 |
| ISLAM KHALID Director | Conversion of Exercise of derivative security | Nov 16, 2023 | 213,825 |
| RALLIS CHRISTOPHER ANIGERON Director | Conversion of Exercise of derivative security | Feb 14, 2025 | 53,020 |
| RAYKOV ROSTISLAV CHRISTOV Director | Sale | Jun 5, 2025 | 65,462 |
Related Tickers
EPRX Eupraxia Pharmaceuticals Inc.
3.9700
+1.28%
WHWK Whitehawk Therapeutics, Inc.
1.9600
+4.81%
HOOK HOOKIPA Pharma Inc.
1.5300
-1.92%
456070.KQ ENCell
13,030.00
+0.77%
HLOSF Healios K.K.
3.1700
0.00%
MEB.F MedinCell S.A.
15.47
-1.40%
BIX0.F BioInvent International AB (publ)
3.5050
+3.70%
RFM.F Sensorion SA
0.4000
+6.67%
2LB.F Iovance Biotherapeutics, Inc.
1.9476
+25.68%
RZLT Rezolute, Inc.
4.3100
-2.71%